YMAB: Y-mAbs Therapeutics , Inc
2020-10-14 09:00:10
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody
2020-10-14 09:00:10
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody